Hospital-acquired vancomycin-resistant enterococci: now appearing in Kuala Lumpur Hospital.
Hospital-acquired vancomycin-resistant enterococci (VRE) were first reported in the late 1980s and have since been an increasing problem worldwide. Kuala Lumpur Hospital thus far, to the best of our knowledge has been spared from this pathogen. We describe the first confirmed case of Enterococcus faecium exhibiting the van A phenotype in our hospital, in a patient with chronic renal failure who was successfully treated with linezolid. The microbiology laboratory plays an important role in the identification and detection of VRE.
Zubaidah
A W
AW
Department of Pathology, Kuala Lumpur Hospital.
Ariza
A
A
Azmi
S
S
D000081:Acetamides / Q000627:therapeutic use; D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology*; D013293:Enterococcus faecalis / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification*; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D006761:Hospitals; D006779:Hospitals, Public; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy; D000069349:Linezolid; D008296:Malaysia; D023303:Oxazolidinones / Q000627:therapeutic use; D010641:Phenotype; D011159:Population Surveillance; D013997:Time Factors; D020713:Vancomycin Resistance / Q000235:genetics*
D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D000069349:Linezolid